吸入式一氧化氮市場規模、佔有率和成長分析（按產品類型、應用、強度、產品、最終用戶和地區）- 產業預測，2025-2032 年

2023 年全球吸入一氧化氮市場規模價值 12 億美元，預計將從 2024 年的 12.9 億美元成長到 2032 年的 23.8 億美元，預測期間（2025-2032 年）的複合年成長率為 7.9%。

一氧化氮是多器官存活和血管健康的必需化學物質，並具有重要的抗菌特性和心臟和腦血管益處。一氧化氮在呼吸治療中很有價值，因為它可以改善通氣灌注匹配並增強動脈氧合。運動員和健身愛好者通常會補充一氧化氮，以促進運動期間的血流量、氧氣輸送和營養吸收，從而推動市場需求。行業主要企業正致力於最佳化氮氣和氧氣等必需氣體的運輸網路，特別是在製藥和醫療保健領域。由於人們對其醫療保健應用的認知不斷提高、心血管和呼吸系統疾病發病率的上升以及持續的研究和開發，吸入一氧化氮市場預計會成長。隨著醫療相關人員越來越意識到一氧化氮的治療益處，對吸入一氧化氮的需求預計將飆升。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

吸入式一氧化氮市場規模（按類型和複合年成長率） (2025-2032)

• 市場概況
• 孩子們
• 成人

吸入式一氧化氮市場規模（依產品類型及複合年成長率） (2025-2032)

• 市場概況
• 吸入式一氧化氮輸送系統
• 耗材
• 一氧化氮氣瓶
• 運輸配件
• 其他

吸入式一氧化氮市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 新生兒呼吸護理
• 慢性阻塞性肺病(COPD)
• 急性呼吸窘迫症候群(ARDS)
• 結核病治療
• 瘧疾治療
• 其他

吸入式一氧化氮市場規模（按強度和複合年成長率） (2025-2032)

• 市場概況
• 100ppm
• 800ppm
• 其他

吸入式一氧化氮市場規模（依產品及複合年成長率） (2025-2032)

• 市場概況
• 一次性的
• 系統

吸入式一氧化氮市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 門診中心
• 診所

吸入式一氧化氮市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Mallinckrodt Pharmaceuticals（United States）
• Key Developments
• Air Liquide Healthcare（France）
• VERO Biotech（United States）
• Getinge AB（Sweden）
• Beyond Air, Inc.（United States）
• SLE Ltd.（United Kingdom）
• Bellerophon Therapeutics（United States）
• International Biomedical（United States）
• NIOX Group plc（United Kingdom）
• BOC Healthcare（United Kingdom）
• Merck KGaA（Germany）
• Nu-Med Plus Inc.（United States）
• Perma Pure LLC（United States）
• HALMA PLC（United Kingdom）
• Matheson Tri-Gas Inc.（United States）
• Circassia Pharmaceuticals（United Kingdom）
• International Biomedical（United States）

結論和建議

Global Inhaled Nitric Oxide Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.29 billion in 2024 to USD 2.38 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

Nitric oxide serves as a vital chemical for multiorgan survival and vascular health, showcasing significant antibacterial properties and cardio-cerebrovascular advantages. It enhances ventilation-perfusion matching and arterial oxygenation, making it invaluable in respiratory therapies. Athletes and fitness enthusiasts commonly supplement with nitric oxide, benefiting from increased blood flow, oxygen delivery, and nutrient absorption during exercise, driving market demand. Key industry players focus on optimizing transport networks for essential gases like nitrogen and oxygen, particularly within the pharmaceutical and healthcare sectors. The inhaled nitric oxide market is poised for growth, propelled by heightened awareness of its healthcare applications, rising rates of cardiovascular and respiratory conditions, and ongoing research developments. As medical professionals recognize its therapeutic benefits, demand for inhaled nitric oxide is expected to surge.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhaled Nitric Oxide market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhaled Nitric Oxide Market Segments Analysis

Global Inhaled Nitric Oxide Market is segmented by Type, Product Type, Application, Strength, Product, End-user and Region. Based on Type, the market is segmented into Pediatric and Adult. Based on Product Type, the market is segmented into Inhaled Nitric Oxide Delivery Systems, Consumables, Nitric Oxide Cylinders, Delivery Accessories and Others. Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Tuberculosis Treatment, Malaria Treatment and Others. Based on Strength, the market is segmented into 100 ppm, 800 ppm and Others. Based on Product, the market is segmented into Disposables and System. Based on End-user, the market is segmented into Hospitals, Ambulatory Centers and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market is greatly influenced by the increasing incidence of respiratory diseases. As these conditions affect a larger segment of the population worldwide, the demand for inhaled nitric oxide as a therapeutic option is expected to rise correspondingly. Various environmental factors, including air pollution, tobacco smoke, and occupational hazards, contribute significantly to respiratory health issues, heightening the risk of developing respiratory conditions. Additionally, the aging population faces diminished immune responses and natural declines in lung function, making them more susceptible to these illnesses. Consequently, as the global population ages, the prevalence of respiratory disorders is likely to escalate.

Restraints in the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market faces several restraints due to stringent regulatory requirements that products must satisfy. The standardisation and approval processes for pharmaceutical products are both costly and time-consuming, which can hinder market growth and slow the introduction of new therapies. Additionally, pricing and reimbursement strategies present substantial regulatory hurdles in various healthcare systems. Companies must engage in complex negotiations with payers to ensure financial reimbursement for their products, all while successfully navigating the intricate landscape of health technology assessment. These factors collectively pose challenges to market accessibility and innovation within the industry.

Market Trends of the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market is witnessing a significant upward trend, primarily driven by the rising prevalence of respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). These conditions, exacerbated by factors like increased smoking and industrialization, pose serious health risks and impair quality of life, thus elevating the need for effective treatments. Inhaled nitric oxide has emerged as a promising therapeutic option for managing these ailments, improving pulmonary function and providing symptomatic relief. As awareness of its benefits spreads and patient populations grow, the market is expected to expand substantially in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Inhaled Nitric Oxide Market Size by Type & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult

Global Inhaled Nitric Oxide Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Inhaled Nitric Oxide Delivery Systems
• Consumables
• Nitric Oxide Cylinders
• Delivery Accessories
• Others

Global Inhaled Nitric Oxide Market Size by Application & CAGR (2025-2032)

• Market Overview
• Neonatal Respiratory Treatment
• Chronic Obstructive Pulmonary Disease (COPD)
• Acute Respiratory Distress Syndrome (ARDS)
• Tuberculosis Treatment
• Malaria Treatment
• Others

Global Inhaled Nitric Oxide Market Size by Strength & CAGR (2025-2032)

• Market Overview
• 100 ppm
• 800 ppm
• Others

Global Inhaled Nitric Oxide Market Size by Product & CAGR (2025-2032)

• Market Overview
• Disposables
• System

Global Inhaled Nitric Oxide Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Centers
• Clinics

Global Inhaled Nitric Oxide Market Size & CAGR (2025-2032)

• North America (Type, Product Type, Application, Strength, Product, End-user)
  • US
  • Canada
• Europe (Type, Product Type, Application, Strength, Product, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Application, Strength, Product, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Application, Strength, Product, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Application, Strength, Product, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Mallinckrodt Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Air Liquide Healthcare (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VERO Biotech (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beyond Air, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SLE Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bellerophon Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIOX Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BOC Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nu-Med Plus Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perma Pure LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HALMA PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matheson Tri-Gas Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Circassia Pharmaceuticals (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations